|
D3ZAC0_RAT |
Itga2b |
Integrin subunit alpha 2b |
1.173e-57 |
0.36
|
ITB3_RAT |
Itgb3 |
Integrin beta-3 |
1.173e-57 |
0.36
|
FABI_STAAR |
fabI |
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI |
4.117e-54 |
0.36
|
FABI_ECOLI |
fabI |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI |
4.581e-41 |
0.63
|
RB_HUMAN |
RB1 |
Retinoblastoma-associated protein |
1.246e-35 |
0.34
|
P2RX7_RAT |
P2rx7 |
P2X purinoceptor 7 |
1.47e-34 |
0.39
|
ADA2A_PIG |
ADRA2A |
Alpha-2A adrenergic receptor |
5.395e-30 |
0.37
|
SSR4_HUMAN |
SSTR4 |
Somatostatin receptor type 4 |
6.866e-30 |
0.36
|
A4TVL0_9PROT |
|
Cereblon isoform 4 |
2.984e-28 |
0.35
|
SSR1_HUMAN |
SSTR1 |
Somatostatin receptor type 1 |
4.871e-28 |
0.33
|
5HT5A_MOUSE |
Htr5a |
5-hydroxytryptamine receptor 5A |
1.132e-27 |
0.45
|
GPVI_HUMAN |
GP6 |
Platelet glycoprotein VI |
2.247e-27 |
0.34
|
5HT6R_MOUSE |
Htr6 |
5-hydroxytryptamine receptor 6 |
2.847e-23 |
0.29
|
DRD5_HUMAN |
DRD5 |
D(1B) dopamine receptor |
1.134e-22 |
0.44
|
TRPA1_RAT |
Trpa1 |
Transient receptor potential cation channel subfamily A member 1 |
2.709e-20 |
0.55
|
SSR2_HUMAN |
SSTR2 |
Somatostatin receptor type 2 |
2.294e-19 |
0.36
|
CRBN_HUMAN |
CRBN |
Protein cereblon |
3.043e-18 |
0.35
|
P2RX7_HUMAN |
P2RX7 |
P2X purinoceptor 7 |
2.397e-17 |
0.39
|
SSR3_HUMAN |
SSTR3 |
Somatostatin receptor type 3 |
2.22e-16 |
0.33
|
TRPM8_MOUSE |
Trpm8 |
Transient receptor potential cation channel subfamily M member 8 |
1.11e-15 |
0.36
|
Q3Y5H1_9GAMC |
|
3C-like protease |
9.326e-15 |
0.36
|
SSR5_HUMAN |
SSTR5 |
Somatostatin receptor type 5 |
1.01e-14 |
0.36
|
ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
6.201e-13 |
0.38
|
TP53B_HUMAN |
TP53BP1 |
TP53-binding protein 1 |
6.449e-13 |
0.28
|
Q5NGQ3_FRATT |
fabI |
Enoyl-[acyl-carrier-protein] reductase [NADH] |
1.4e-12 |
0.31
|
CAH3_BOVIN |
CA3 |
Carbonic anhydrase 3 |
1.511e-12 |
0.28
|
DYR_STAAW |
folA |
Dihydrofolate reductase |
2.558e-12 |
0.36
|
NPSR1_HUMAN |
NPSR1 |
Neuropeptide S receptor |
8.518e-12 |
0.33
|
NEK3_HUMAN |
NEK3 |
Serine/threonine-protein kinase Nek3 |
5.659e-11 |
0.29
|
BAZ2B_HUMAN |
BAZ2B |
Bromodomain adjacent to zinc finger domain protein 2B |
8.342e-10 |
0.41
|
HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
8.493e-10 |
0.39
|
PARP3_HUMAN |
PARP3 |
Protein mono-ADP-ribosyltransferase PARP3 |
1.014e-09 |
0.31
|
ADA2C_HUMAN |
ADRA2C |
Alpha-2C adrenergic receptor |
1.9e-09 |
0.38
|
DRD1_HUMAN |
DRD1 |
D(1A) dopamine receptor |
1.933e-09 |
0.44
|
STK38_HUMAN |
STK38 |
Serine/threonine-protein kinase 38 |
2.039e-09 |
0.29
|
ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
3.335e-09 |
0.38
|
CAC1C_RAT |
Cacna1c |
Voltage-dependent L-type calcium channel subunit alpha-1C |
5.064e-09 |
0.37
|
AVR2A_HUMAN |
ACVR2A |
Activin receptor type-2A |
7.778e-09 |
0.29
|
MK06_HUMAN |
MAPK6 |
Mitogen-activated protein kinase 6 |
7.778e-09 |
0.29
|
ST38L_HUMAN |
STK38L |
Serine/threonine-protein kinase 38-like |
7.778e-09 |
0.29
|
NEK9_HUMAN |
NEK9 |
Serine/threonine-protein kinase Nek9 |
2.422e-08 |
0.29
|
TLK2_HUMAN |
TLK2 |
Serine/threonine-protein kinase tousled-like 2 |
2.422e-08 |
0.29
|
MYO3A_HUMAN |
MYO3A |
Myosin-IIIa |
6.44e-08 |
0.29
|
OXSR1_HUMAN |
OXSR1 |
Serine/threonine-protein kinase OSR1 |
6.44e-08 |
0.29
|
STK39_HUMAN |
STK39 |
STE20/SPS1-related proline-alanine-rich protein kinase |
6.44e-08 |
0.29
|
MRCKG_HUMAN |
CDC42BPG |
Serine/threonine-protein kinase MRCK gamma |
1.511e-07 |
0.29
|
MYO3B_HUMAN |
MYO3B |
Myosin-IIIb |
1.511e-07 |
0.29
|
ST32A_HUMAN |
STK32A |
Serine/threonine-protein kinase 32A |
1.511e-07 |
0.29
|
PARP2_HUMAN |
PARP2 |
Poly [ADP-ribose] polymerase 2 |
2.141e-07 |
0.39
|
PARP1_HUMAN |
PARP1 |
Poly [ADP-ribose] polymerase 1 |
2.95e-07 |
0.45
|
NEK5_HUMAN |
NEK5 |
Serine/threonine-protein kinase Nek5 |
3.205e-07 |
0.29
|
NEK7_HUMAN |
NEK7 |
Serine/threonine-protein kinase Nek7 |
3.205e-07 |
0.29
|
SBK3_HUMAN |
SBK3 |
Uncharacterized serine/threonine-protein kinase SBK3 |
3.205e-07 |
0.29
|
SIK3_HUMAN |
SIK3 |
Serine/threonine-protein kinase SIK3 |
3.205e-07 |
0.29
|
SRPK2_HUMAN |
SRPK2 |
SRSF protein kinase 2 |
3.205e-07 |
0.29
|
STK11_HUMAN |
STK11 |
Serine/threonine-protein kinase STK11 |
3.205e-07 |
0.29
|
TLK1_HUMAN |
TLK1 |
Serine/threonine-protein kinase tousled-like 1 |
3.205e-07 |
0.29
|
NISCH_HUMAN |
NISCH |
Nischarin |
4.922e-07 |
0.43
|
ADA2A_BOVIN |
ADRA2A |
Alpha-2A adrenergic receptor |
5.593e-07 |
0.37
|
HUNK_HUMAN |
HUNK |
Hormonally up-regulated neu tumor-associated kinase |
6.257e-07 |
0.29
|
NIM1_HUMAN |
NIM1K |
Serine/threonine-protein kinase NIM1 |
6.257e-07 |
0.29
|
PRP4B_HUMAN |
PRPF4B |
Serine/threonine-protein kinase PRP4 homolog |
6.257e-07 |
0.29
|
WEE2_HUMAN |
WEE2 |
Wee1-like protein kinase 2 |
6.257e-07 |
0.29
|
CDK15_HUMAN |
CDK15 |
Cyclin-dependent kinase 15 |
1.14e-06 |
0.29
|
LATS1_HUMAN |
LATS1 |
Serine/threonine-protein kinase LATS1 |
1.14e-06 |
0.29
|
SGK3_HUMAN |
SGK3 |
Serine/threonine-protein kinase Sgk3 |
1.14e-06 |
0.29
|
AVR2B_HUMAN |
ACVR2B |
Activin receptor type-2B |
1.959e-06 |
0.29
|
KCC1G_HUMAN |
CAMK1G |
Calcium/calmodulin-dependent protein kinase type 1G |
1.959e-06 |
0.29
|
SBK1_HUMAN |
SBK1 |
Serine/threonine-protein kinase SBK1 |
1.959e-06 |
0.29
|
STK24_HUMAN |
STK24 |
Serine/threonine-protein kinase 24 |
1.959e-06 |
0.29
|
KLK7_HUMAN |
KLK7 |
Kallikrein-7 |
2.081e-06 |
0.34
|
ADA2B_RAT |
Adra2b |
Alpha-2B adrenergic receptor |
3.118e-06 |
0.37
|
BRSK2_HUMAN |
BRSK2 |
Serine/threonine-protein kinase BRSK2 |
3.203e-06 |
0.29
|
NEK6_HUMAN |
NEK6 |
Serine/threonine-protein kinase Nek6 |
3.203e-06 |
0.29
|
PAK6_HUMAN |
PAK6 |
Serine/threonine-protein kinase PAK 6 |
3.203e-06 |
0.29
|
RIPK4_HUMAN |
RIPK4 |
Receptor-interacting serine/threonine-protein kinase 4 |
3.203e-06 |
0.29
|
PE2R2_HUMAN |
PTGER2 |
Prostaglandin E2 receptor EP2 subtype |
3.551e-06 |
0.35
|
V1AR_MOUSE |
Avpr1a |
Vasopressin V1a receptor |
3.847e-06 |
0.29
|
MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
4.142e-06 |
0.29
|
CILK1_HUMAN |
CILK1 |
Serine/threonine-protein kinase ICK |
5.02e-06 |
0.29
|
INSRR_HUMAN |
INSRR |
Insulin receptor-related protein |
5.02e-06 |
0.29
|
M3K4_HUMAN |
MAP3K4 |
Mitogen-activated protein kinase kinase kinase 4 |
5.02e-06 |
0.29
|
MYLK3_HUMAN |
MYLK3 |
Myosin light chain kinase 3 |
5.02e-06 |
0.29
|
MYLK4_HUMAN |
MYLK4 |
Myosin light chain kinase family member 4 |
5.02e-06 |
0.29
|
NMDE2_RAT |
Grin2b |
Glutamate receptor ionotropic, NMDA 2B |
5.123e-06 |
0.43
|
CDK14_HUMAN |
CDK14 |
Cyclin-dependent kinase 14 |
7.581e-06 |
0.29
|
DUSTY_HUMAN |
DSTYK |
Dual serine/threonine and tyrosine protein kinase |
7.581e-06 |
0.29
|
LATS2_HUMAN |
LATS2 |
Serine/threonine-protein kinase LATS2 |
7.581e-06 |
0.29
|
MP2K6_HUMAN |
MAP2K6 |
Dual specificity mitogen-activated protein kinase kinase 6 |
7.581e-06 |
0.29
|
PI42B_HUMAN |
PIP4K2B |
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta |
7.581e-06 |
0.29
|
LMBL1_HUMAN |
L3MBTL1 |
Lethal(3)malignant brain tumor-like protein 1 |
8.502e-06 |
0.29
|
NMBR_HUMAN |
NMBR |
Neuromedin-B receptor |
9.383e-06 |
0.30
|
EDNRA_PIG |
EDNRA |
Endothelin-1 receptor |
9.639e-06 |
0.30
|